Banner: investors



PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena-- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain Silver Dihydrogen Citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area).

Inquiries about stock accounts, or change in name or address may be directed to PURE Bioscience's stock transfer agent:

Transfer Online, Inc.
Attn: Rose Fredericks 
512 SE Salmon St.
Portland, OR 97214
503-227-2950 ext. 235

Other investor inquires may be directed to:

Hank Lambert 
Chief Executive Officer

Terri MacInnis, VP of IR
Bibicoff + MacInnis, Inc.

Receive Report Materials Electronically
Shareholders may opt for the convenience of electronic shareholder materials. Subscribers receive messages containing links to the online annual report and proxy statement, and may vote their proxies online. Interested shareholders may sign up here.